Elanco Animal Health ELAN
NYSE ELAN
$23.61 -0.89 (-3.61%)
At close: Aug 20, 2026 · 1:03 PM UTC

Elanco Animal Health (ELAN) Net Income towards Common Stockholders Growth (1y) (2018 - 2026)

Elanco Animal Health (ELAN) Net Income towards Common Stockholders Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Haleon 43.92 Bn 42.96 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.53 Bn 2.15 Bn -304.98%
3 Zoetis 31.74 Bn 30.06 Bn 1.05 Bn -5.04%
4 Takeda Pharmaceutical 28.67 Bn 22.87 Bn 5.10 Bn -17.29%
5 United Therapeutics 22.22 Bn 19.56 Bn 683.80 Mn 7.59%
6 Viatris 18.71 Bn 17.83 Bn 1.46 Bn -2,482.61%
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn 34.33%
8 Elanco Animal Health 11.80 Bn 11.27 Bn 798.00 Mn 390.91%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.12 Bn 7.47 Bn 397.90 Mn -99.40%

Historic Data

Download Data
DateValue
Jun 30, 2026 390.91%
Mar 31, 2026 -14.93%
Dec 31, 2025 -3,350.00%
Sep 30, 2025 -109.34%
Jun 30, 2025 122.00%
Mar 31, 2025 109.38%
Dec 31, 2024 94.33%
Sep 30, 2024 133.21%
Jun 30, 2024 48.45%
Mar 31, 2024 -68.93%
Dec 31, 2023 -161.11%
Sep 30, 2023 -1,586.15%
Jun 30, 2023 -870.00%
Mar 31, 2023 101.96%
Dec 31, 2022 48.57%
Sep 30, 2022 39.81%
Jun 30, 2022 95.15%
Mar 31, 2022 179.69%
Dec 31, 2021 67.47%
Sep 30, 2021 20.00%